Embed Size (px)
Citation preview
CENTRAL NERVOUS SYSTEM (CNS) MARKET
Forecast – 2014 To 2022
In-depth analysis of the market segments that will showcase the greatest growth potential
Information about the technological advancements influencing the growth of the global market
Extensive analysis of the key players dominating the competitive landscape of this market
Browse the report : Central Nervous System (CNS) Market
Key Benefits Of The Report
According to Alzheimer’s Association, as of 2016 5.4 million people are suffering from Alzheimer’s disease in America and these figures will triple up by 2050. It means, one in every nine people above the age of 65 has Alzheimer's disease. This is considered to be one of the major driving factors for the global central nervous system (CNS) market.
The rapidly increasing geriatric population and increasing age of baby boomers are creating a strong rise in the diseases such as Parkinson's, Alzheimer's, and various mental disorders. This is expected to drive the global market during the forecast period.
Limited availability of the medicines available for the treatment of the central nervous system-related diseases and disorders is one of the major growth drivers for the global central nervous system (CNS) market.
Pharmaceutical companies such as Novartis, Eli Lilly, and GlaxoSmithKline are making heavy investments to develop the most effective drugs for the complete cure of the CNS-related diseases and disorders, which is also considered as one of the growth drivers for this market during the next few years.
Browse the report : Central Nervous System (CNS) Market
Key Premium Industry Insights
The research methodology for Scalar Market Research’s central nervous system (CNS) market report utilizes a combination of top-down and bottom-up research formats.
Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.
Download Sample : Central Nervous System (CNS) Market
Research Methodology
Market Segmentation
Central Nervous System Market, by Neurological Disorders Alzheimer’s Disease Parkinson’s Disease Epilepsy Brain Tumor Stroke
Central Nervous System Market, By Mental Disorders Anxiety Disorder Sleep Disorder Mental Retardation Multiple Sclerosis
Novartis A.G. Pfizer, Inc. Johnson and Johnson Eli Lilly and Company Sanofi SA Abbott Laboratories Merck & Co. Bristol Myers Squibb Company Astellas Pharma Inc. GlaxoSmithKline Plc UCB S.A.
Key Players
• Asia-Pacific• Europe• North America• Rest of the World
Geographic Coverage & Analysis
Find out more about our services at : www.scalarmarketresearch.comContact :
8770 W Bryn Mawr Ave.,Suite 1300
Chicago, IL 60631 Tel. : +1-800-213-5170 (U.S./Canada Toll-free)
Email : [email protected] us on LinkedIn: https://www.linkedin.com/company/scalar-market-research
Contact Info
Related Reports :1. Biosimilars Market2. Stem Cell Therapy Market3. Home Healthcare Market
Thank You
